Synthetic Biology and the Chem/Bio ThreatSecrecy News (blog)Synthetic biology, a set of technologies related to the design and fabrication of biological systems, poses an emerging hazard but also provides the tools to mitigate that hazard, according to… Continue reading
Vascular disease Trialling stem cell treatment for vascular diseaseNature.comIn a study of mesenchymal stem cells (MSCs) to treat atherosclerotic renovascular disease, 28 patients received standard medical treatment, 14 of whom also received a single i… Continue reading
Financial Times |
Big pharma turns to immunotherapy combos to beat cancer
Financial Times Merck last week became the first company to win approval to use its immunotherapy Keytruda in all patients whose tumours have a particular biological trait or “biomarker”, regardless of where the cancer is located. At Asco, it is due to present full … |
|
Celyad obtains additional US patent for allogeneic cancer treatment based on TCR-deficient CAR–T cells
Business Wire (press release) “Allogeneic CAR–T cells are of increasing interest to many Pharma and BioPharma companies involved in cell-based cancer immunotherapies. We are looking to maximize the significant value of our allogeneic CAR-T assets through strategic collaborations … |
|
Celyad obtains additional US patent for allogeneic cancer treatment based on TCR-deficient CAR–T cells
Business Wire (press release) “Allogeneic CAR–T cells are of increasing interest to many Pharma and BioPharma companies involved in cell-based cancer immunotherapies. We are looking to maximize the significant value of our allogeneic CAR-T assets through strategic collaborations … |